GALIMBERTI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 236
EU - Europa 103
AS - Asia 30
AF - Africa 1
Totale 370
Nazione #
US - Stati Uniti d'America 235
IT - Italia 23
IE - Irlanda 21
SE - Svezia 20
DE - Germania 17
HK - Hong Kong 12
GB - Regno Unito 7
SG - Singapore 7
RU - Federazione Russa 5
ID - Indonesia 4
BE - Belgio 3
FI - Finlandia 3
TR - Turchia 3
CN - Cina 2
UA - Ucraina 2
CA - Canada 1
CZ - Repubblica Ceca 1
IN - India 1
JP - Giappone 1
RO - Romania 1
SC - Seychelles 1
Totale 370
Città #
Ann Arbor 70
Fairfield 26
Ashburn 20
Dublin 20
Chandler 14
Frankfurt am Main 11
Hong Kong 11
Princeton 10
Wilmington 10
Woodbridge 10
New York 8
Houston 7
Cagliari 6
Dearborn 6
Seattle 6
Milan 5
Andover 4
Cambridge 4
Jacksonville 4
Jakarta 4
Lawrence 4
San Diego 4
Bergamo 3
Brussels 3
Singapore 3
Altamura 2
Istanbul 2
Nanjing 2
Boardman 1
Chula Vista 1
Falls Church 1
Helsinki 1
Iasi 1
Inveruno 1
Jalgaon 1
Lachine 1
Lappeenranta 1
London 1
Ludwigshafen am Rhein 1
Matelica 1
Merced 1
Phoenix 1
San Mateo 1
Santa Clara 1
Solbiate Olona 1
Tappahannock 1
Wandsworth 1
Washington 1
Totale 299
Nome #
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 168
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis 64
Dendrimeric tetravalent ligands for the serotonin-gated ion channel 62
Preliminary characterization of CR13626, a novel tyrosine kinase inhibitor for the treatment of glioblastoma. 54
CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma 49
Totale 397
Categoria #
all - tutte 1.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 5 2 2 3 6 5 3 3 3 1 3 2
2020/202122 1 3 3 3 1 2 1 3 1 2 2 0
2021/2022132 19 57 19 8 2 0 3 4 1 6 6 7
2022/202396 11 26 7 5 10 18 0 7 5 0 2 5
2023/202463 4 6 0 1 9 9 8 7 6 2 2 9
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 397